B Braun Medical Inc: Dextrose Injection Usp, 70%

Summary B. Braun Medical Inc. is recalling 2000 mL bags of Dextrose Injection USP, 70% distributed nationwide because the product may leak from the diaphragm port after the foil is removed, which could compromise its sterility. This is a Class II recall affecting prescription injectable dextrose products sold across all U.S. states and Washington, D.C.

Recalling firm
B BRAUN MEDICAL INC
Product
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Reason
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-04-02
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
US Nationwide.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/d0ce287f-03e3-461e-a23e-1f03cae08bd8